Reply to Scheper and de Boer's comment on "Duration of rifampin therapy is a key determinant of improved outcomes in early-onset acute prosthetic joint infection due to Staphylococcus treated with a debridement, antibiotics and implant retention (DAIR): a retrospective multicenter study in France" by Becker et al. (2020)

J Bone Jt Infect. 2020 Jul 22;6(1):19-20. doi: 10.5194/jbji-6-19-2020. eCollection 2020.

Agathe Becker^{1

2}, Louis Kreitmann^{1

3}, Tristan Ferry^{1

2

3

4}

¹ Service des Maladies Infectieuses et Tropicales, Centre hospitalier universitaire (CHU) de la Croix Rousse, Hospices Civils de Lyon (HCL), Lyon, France.
² Centre de Référence des Infections Ostéo-Articulaires Complexes (CRIOAc) de Lyon, Lyon, France.
³ Faculté de Médecine Lyon-Est, Université Claude Bernard Lyon 1, Lyon, France.
⁴ Inserm U1111, Centre international de recherche en Infectiologie (CIRI), Université Claude-Bernard Lyon 1, Lyon, France.

No abstract available